Why Ocugen, Inc. (OCGN) Stock Constantly Declining? Here You Would Get the Answer
Ocugen, Inc. (OCGN), a clinical-stage biopharmaceutical company, has declined 6.13% during the aftermarket trading session and consequently, was trading at $11.95 at the time of